
    
      An Open Label, Randomized, 2-period, 2- Treatment, 2-Sequence, Crossover, Single-dose
      Bioequivalence Study of Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
      containing Olmesartan medoxomil 40 mg, Amlodipine 10 mg and Hydrochlorothiazide 25 mg ( Test
      Formulation, Torrent Pharmaceutical Ltd., India) Versus TribenzorÂ® 40+10+25 mg Tablets
      containing Olmesartan medoxomil 40 mg, Amlodipine 10 mg and Hydrochlorothiazide 25 mg
      (Reference , Daichi Sankyo Inc., USA) in Healthy Human Volunteers Under Fed Condition.
    
  